Technical
Channels

Drug Discovery

Drug Development

Drug Manufacturing

Drug Delivery

Clinical Trials

Regulatory and Legal

Alliances and Mergers

QA/QC and Compliance

Pharmaceutical Processing and Packaging

Change text size [+] [-]

PharmChina: 100,000 Attendees Expected

Thursday, March 01, 2007
 Email This |  Printer Friendly

The 57th PharmChina, deemed the largest pharmaceutical fair in China, will be held from April 19 to 21, 2007, in the Dalian World Expo Center (Dalian Xinghai Square). The 60,000-sqm exhibition will focus on pharmaceutical R&D, manufacturing, distribution, and relevant service supply to companies inthe booming market.

The PharmChina Summit Forum features a high-level conference that covers hot topics related to the latest developments and trends in the global health and pharmaceutical industry through a series of discussions and interesting sessions. Speakers from the pharmaceutical industry and the government will discuss and share with delegates presentations on issues including the latest pharmaceutical development, laws and regulations of drug administration, and pharmaceuticalmarket trends.

More than 100,000 visitors are expected to attend the show and will include representatives from manufacturers, distributors, R&D houses, consultancy companies, andend-users of the pharmaceutical industry.

The approximately 2,300 companies expected to exhibit will be comprised of leading pharmaceutical manufacturers, pharmaceutical distributors, and competitive pharmaceutical service suppliers.

Show organizer Reed Sinopharm Exhibitions says products and services to be showcased will include chemicals, Chinese-patented medicines, biopharmaceuticals, OTC medicines, healthcare products, and pharmaceutical technologies and services.

The show is supported by the Ministry of Commerce of the People's Republic of China, People's Government of Liaoning Municipality, and China Pharmaceutical Industry Association. PA

For more information, see http://en.pharmchina.com.cn/


Share this:   Del.icio.us | 
Digital Edition



Singapore's Preclinical R&D industry should differentiate itself in Asia by competing on quality rather than on price.
Yes
No
View results


ABOUT PHARMA ASIA | FREE SUBSCRIPTION | CONTACT US

© 2010 Ten Alps Communications Asia. All rights reserved.
Use of this Web site is subjected to its Terms and Conditions of Use. View our Privacy Policy